Pharma Ups the Dividend Ante

There's no way to sugarcoat this: It was not a pretty year for pharmaceutical companies. While the S&P saw substantial gains over the last year, with the exception of Bristol-Myers Squibb (NYSE: BMY) and Novartis (NYSE: NVS), every other major pharmaceutical company listed on the U.S. exchange saw their shares decrease. And neither of the two that were in positive territory actually surpassed the S&P 500.... Read more